Abstract |
Oncofetal markers for colon carcinomas are CSAp, a nonsulfated mucin, a second trimester fetal antigen, an altered thymidine kinase, a monosialoganglioside, and glycolipid antigens. For gastric carcinoma, they are basic fetoprotein, a sulfoglycoprotein, and for pancreatic carcinomas--POA, an oncofetal pancreatic antigen, and designated as CAPI, an oncofetal antigen. Tumor-associated markers for colon carcinomas are: UDP- galactosyltransferase and zinc glycinate marker; for gastric carcinomas, sulfated glycoprotein and for pancreatic carcinomas, pancreas carcinoma-associated antigen, a polycytidylic acid-specific ribonuclease, and galactosyltransferase. Suggested as tumor-specific markers for colon carcinomas are an altered mucoprotein, basic antigen, beta 2-microglobulin-associated antigen, and a specific adenosine deaminase; for gastric carcinomas, a specific protein, an antigen with 3-oxyanthranilic acid, and an antigen of unknown origin in gastric secretions; for pancreatic carcinomas, an antigen with molecular weight of 380,000 daltons and an antigen suggested by tumor immunity.
|
Authors | J V Klavins |
Journal | Cancer detection and prevention
(Cancer Detect Prev)
Vol. 6
Issue 1-2
Pg. 131-6
( 1983)
ISSN: 0361-090X [Print] England |
PMID | 6883374
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Neoplasm
- oncofetal antigens
|
Topics |
- Antigens, Neoplasm
(analysis)
- Colonic Neoplasms
(analysis)
- Gastrointestinal Neoplasms
(analysis)
- Humans
- Pancreatic Neoplasms
(analysis)
- Stomach Neoplasms
(analysis)
|